Barbara Testoni
UMR Inserm 1052 CNRS 5286 Mixte, CLB
Lyon, France
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
B-BEST: Profiling the intrahepatic HBV reservoir at single-cell resolution.
Journal: Hepatology (Baltimore, Md.)
Published: April 17, 2026
Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts.
Journal: Nature reviews. Gastroenterology & hepatology
Published: March 12, 2026
Adenine Base Editing Potently Suppresses Hepatitis B Surface Antigen Expression and Inhibits Hepatitis D Virus Release.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation.
Journal: Alimentary pharmacology & therapeutics
Published: September 04, 2025
Role of cccDNA in the Quest for HBV Cure- Implications for HIV-HBV Coinfection.
Journal: Current HIV/AIDS reports
Published: August 27, 2025
Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe.
Journal: JHEP reports : innovation in hepatology
Published: June 20, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.
Journal: Journal of hepatology
Published: April 11, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines.
Journal: The lancet. Gastroenterology & hepatology
Published: November 07, 2024
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.
Journal: eGastroenterology
Published: October 30, 2024
Last Updated: 09/26/2026